Your browser doesn't support javascript.
Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study.
de Rojas, Itziar; Hernández, Isabel; Montrreal, Laura; Quintela, Inés; Calero, Miguel; Royo, Jose Luís; Huerto Vilas, Raquel; González-Pérez, Antonio; Franco-Macías, Emilio; Macías, Juan; Menéndez-González, Manuel; Frank-García, Ana; Diez-Fairen, Mónica; Lage, Carmen; García-Madrona, Sebastián; Aguilera, Nuria; García-González, Pablo; Puerta, Raquel; Sotolongo-Grau, Oscar; Alonso-Lana, Silvia; Rábano, Alberto; Arias Pastor, Alfonso; Pastor, Ana Belén; Corma-Gómez, Anaïs; Martín Montes, Angel; Martínez Rodríguez, Carmen; Buiza-Rueda, Dolores; Periñán, Maria Teresa; Rodriguez-Rodriguez, Eloy; Alvarez, Ignacio; Rosas Allende, Irene; Pineda, Juan A; Bernal Sánchez-Arjona, María; Fernández-Fuertes, Marta; Mendoza, Silvia; Del Ser, Teodoro; Garcia-Ribas, Guillermo; Sánchez-Juan, Pascual; Pastor, Pau; Bullido, María J; Álvarez, Victoria; Real, Luis M; Mir, Pablo; Piñol-Ripoll, Gerard; García-Alberca, Jose María; Medina, Miguel; Orellana, Adelina; Butler, Chris R; Marquié, Marta; Sáez, María Eugenia.
  • de Rojas I; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Hernández I; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Montrreal L; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Quintela I; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Calero M; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Royo JL; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII), Universidade de Santiago de Compostela, 15705 Santiago de Compostela, Spain.
  • Huerto Vilas R; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • González-Pérez A; UFIEC, Instituto de Salud Carlos III, 28220 Madrid, Spain.
  • Franco-Macías E; CIEN Foundation/Queen Sofia Foundation Alzheimer Center, 28220 Madrid, Spain.
  • Macías J; Depatamento de Especialidades Quirúrgicas, Bioquímica e Inmunología, Facultad de Medicina, Universidad de Málaga, 29016 Málaga, Spain.
  • Menéndez-González M; Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, 25198 Lleida, Spain.
  • Frank-García A; Institut de Recerca Biomedica de Lleida (IRBLLeida), 25198 Lleida, Spain.
  • Diez-Fairen M; CAEBI, Centro Andaluz de Estudios Bioinformáticos, 41013 Sevilla, Spain.
  • Lage C; Unidad de Demencias, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • García-Madrona S; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, 41013 Sevilla, Spain.
  • Aguilera N; Servicio de Neurología, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
  • García-González P; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Asturias, Spain.
  • Puerta R; Departamento de Medicina, Universidad de Oviedo, 33011 Oviedo, Spain.
  • Sotolongo-Grau O; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Alonso-Lana S; Department of Neurology, University Hospital La Paz-Universidad Autónoma-Madrid, 28046 Madrid, Spain.
  • Rábano A; University Hospital La Paz Research Institute (IdiPaz), 28029 Madrid, Spain.
  • Arias Pastor A; Fundació Docència i Recerca MútuaTerrassa, 08221 Terrassa, Spain.
  • Pastor AB; Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, 08221 Terrassa, Spain.
  • Corma-Gómez A; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Martín Montes A; Neurology Service, Marqués de Valdecilla University Hospital (University of Cantabria and IDIVAL), 39008 Santander, Spain.
  • Martínez Rodríguez C; Hospital Universitario Ramon y Cajal, IRYCIS, 28034 Madrid, Spain.
  • Buiza-Rueda D; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Periñán MT; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Rodriguez-Rodriguez E; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Alvarez I; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Rosas Allende I; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Pineda JA; Research Center and Memory Clinic, Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Bernal Sánchez-Arjona M; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Fernández-Fuertes M; CIEN Foundation/Queen Sofia Foundation Alzheimer Center, 28220 Madrid, Spain.
  • Mendoza S; Banco de Tejidos de la Fundación CIEN, 28034 Madrid, Spain.
  • Del Ser T; Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, 25198 Lleida, Spain.
  • Gr Ace/Degesco Consortium; Institut de Recerca Biomedica de Lleida (IRBLLeida), 25198 Lleida, Spain.
  • Garcia-Ribas G; CIEN Foundation/Queen Sofia Foundation Alzheimer Center, 28220 Madrid, Spain.
  • Sánchez-Juan P; Banco de Tejidos de la Fundación CIEN, 28034 Madrid, Spain.
  • Pastor P; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, 41013 Sevilla, Spain.
  • Bullido MJ; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Álvarez V; Department of Neurology, University Hospital La Paz-Universidad Autónoma-Madrid, 28046 Madrid, Spain.
  • Real LM; University Hospital La Paz Research Institute (IdiPaz), 28029 Madrid, Spain.
  • Mir P; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Asturias, Spain.
  • Piñol-Ripoll G; Hospital de Cabueñes, 33394 Gijón, Spain.
  • García-Alberca JM; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Medina M; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Orellana A; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
  • Butler CR; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Marquié M; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220 Madrid, Spain.
J Pers Med ; 11(12)2021 Dec 07.
Article in English | MEDLINE | ID: covidwho-1554837
ABSTRACT
Emerging studies have suggested several chromosomal regions as potential host genetic factors involved in the susceptibility to SARS-CoV-2 infection and disease outcome. We nested a COVID-19 genome-wide association study using the GR@ACE/DEGESCO study, searching for susceptibility factors associated with COVID-19 disease. To this end, we compared 221 COVID-19 confirmed cases with 17,035 individuals in whom the COVID-19 disease status was unknown. Then, we performed a meta-analysis with the publicly available data from the COVID-19 Host Genetics Initiative. Because the APOE locus has been suggested as a potential modifier of COVID-19 disease, we added sensitivity analyses stratifying by dementia status or by disease severity. We confirmed the existence of the 3p21.31 region (LZTFL1, SLC6A20) implicated in the susceptibility to SARS-CoV-2 infection and TYK2 gene might be involved in COVID-19 severity. Nevertheless, no statistically significant association was observed in the COVID-19 fatal outcome or in the stratified analyses (dementia-only and non-dementia strata) for the APOE locus not supporting its involvement in SARS-CoV-2 pathobiology or COVID-19 prognosis.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Reviews Language: English Year: 2021 Document Type: Article Affiliation country: Jpm11121318

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Reviews Language: English Year: 2021 Document Type: Article Affiliation country: Jpm11121318